• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cervical cancer screening: Epidemiology as the necessary but not sufficient basis of public health practice.

作者信息

Schiffman Mark

机构信息

Clinical Genetics Branch, NCI, 9609 Medical Center Drive, Rockville, MD 20850, USA.

出版信息

Prev Med. 2017 May;98:3-4. doi: 10.1016/j.ypmed.2016.12.028. Epub 2017 Feb 6.

DOI:10.1016/j.ypmed.2016.12.028
PMID:28279258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5347462/
Abstract
摘要

相似文献

1
Cervical cancer screening: Epidemiology as the necessary but not sufficient basis of public health practice.宫颈癌筛查：流行病学作为公共卫生实践的必要但不充分依据。
Prev Med. 2017 May;98:3-4. doi: 10.1016/j.ypmed.2016.12.028. Epub 2017 Feb 6.
2
The renewal of the National Cervical Screening Program.国家宫颈癌筛查计划的更新。
Med J Aust. 2016 Oct 17;205(8):357-358. doi: 10.5694/mja16.00820.
3
Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.按年龄划分的宫颈癌筛查和发病情况：接近和超过筛查停止年龄后的未满足需求。
Am J Prev Med. 2017 Sep;53(3):392-395. doi: 10.1016/j.amepre.2017.02.024. Epub 2017 May 1.
4
Cervical Cancer Screening: More Choices in 2019.宫颈癌筛查：2019年有更多选择
JAMA. 2019 May 28;321(20):2018-2019. doi: 10.1001/jama.2019.4595.
5
Cervical cancer screening in Santiago Atitlán, Guatemala.危地马拉圣胡安阿蒂特兰的宫颈癌筛查
Int J Gynaecol Obstet. 2016 Oct;135(1):119. doi: 10.1016/j.ijgo.2016.04.010. Epub 2016 Jul 2.
6
Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.2007年至2013年法国25岁以下女性的宫颈癌筛查及后续程序：一项基于法国全国医疗保健数据库的研究
Eur J Cancer Prev. 2018 Sep;27(5):479-485. doi: 10.1097/CEJ.0000000000000360.
7
Cervical cancer screening practices among women in Ghana: evidence from wave 2 of the WHO study on global AGEing and adult health.加纳女性的宫颈癌筛查实践：来自世卫组织全球老龄化和成人健康研究第二波调查的证据。
BMC Womens Health. 2020 Mar 5;20(1):49. doi: 10.1186/s12905-020-00915-9.
8
Breast and cervical cancer screening for women with intellectual disabilities.为智障女性进行乳腺癌和宫颈癌筛查。
Health Soc Work. 2013 Aug;38(3):183-6. doi: 10.1093/hsw/hlt012.
9
Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".优化宫颈癌筛查：评《人乳头瘤病毒检测与巴氏涂片检测联合用于宫颈癌筛查与单独巴氏涂片检测的比较》
Arch Intern Med. 2010 Jun 14;170(11):985-6. doi: 10.1001/archinternmed.2010.133.
10
Cervical cancer screening and updated Pap guidelines.宫颈癌筛查与更新后的巴氏涂片指南。
Prim Care. 2009 Mar;36(1):131-49, ix. doi: 10.1016/j.pop.2008.10.008.

引用本文的文献

1
Resveratrol Enhances the Anti-Cancer Effects of Cis-Platinum on Human Cervical Cancer Cell Lines by Activating the SIRT3 Relative Anti-Oxidative Pathway.白藜芦醇通过激活SIRT3相关抗氧化途径增强顺铂对人宫颈癌细胞系的抗癌作用。
Front Pharmacol. 2022 Jul 5;13:916876. doi: 10.3389/fphar.2022.916876. eCollection 2022.
2
KIF14 affects cell cycle arrest and cell viability in cervical cancer by regulating the p27 pathway.KIF14 通过调节 p27 通路影响宫颈癌细胞周期阻滞和细胞活力。
World J Surg Oncol. 2022 Apr 19;20(1):125. doi: 10.1186/s12957-022-02585-3.
3
TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.TIM-1 通过 PI3K/AKT/p53 通路促进宫颈癌的增殖和转移，抑制凋亡。
BMC Cancer. 2022 Apr 7;22(1):370. doi: 10.1186/s12885-022-09386-7.
4
Daidzin inhibits growth and induces apoptosis through the JAK2/STAT3 in human cervical cancer HeLa cells.大豆苷元通过JAK2/STAT3信号通路抑制人宫颈癌HeLa细胞的生长并诱导其凋亡。
Saudi J Biol Sci. 2021 Dec;28(12):7077-7081. doi: 10.1016/j.sjbs.2021.08.011. Epub 2021 Aug 8.
5
Connaissances, utilisation et obstacles liés au dépistage du cancer du col utérin dans des hôpitaux de district de Kigali, au Rwanda.卢旺达基加利地区医院子宫颈癌筛查的相关知识、应用及障碍
Can Oncol Nurs J. 2021 Jul 1;31(3):275-284. doi: 10.5737/23688076313275284. eCollection 2021 Summer.
6
Knowledge, utilization and barriers of cervical cancer screening among women attending selected district hospitals in Kigali - Rwanda.卢旺达基加利部分地区医院女性宫颈癌筛查的认知、利用情况及障碍
Can Oncol Nurs J. 2021 Jul 1;31(3):266-274. doi: 10.5737/23688076313266274. eCollection 2021 Summer.
7
Knowledge of Risk Factors, Symptoms and Barriers to Seeking Medical Help for Cervical Cancer among Omani Women Attending Sultan Qaboos University Hospital.阿曼妇女在苏尔坦·卡布斯大学医院就诊时对宫颈癌的危险因素、症状和寻求医疗帮助的障碍的认知。
Sultan Qaboos Univ Med J. 2020 Aug;20(3):e301-e309. doi: 10.18295/squmj.2020.20.03.009. Epub 2020 Oct 5.
8
Long non-coding RNA HOTAIR regulates proliferation, migration and invasion of human cervical cancer cells by modulating expression of MAPK1.长链非编码RNA HOTAIR通过调节MAPK1的表达来调控人宫颈癌细胞的增殖、迁移和侵袭。
Arch Med Sci. 2019 Mar 11;16(5):1158-1165. doi: 10.5114/aoms.2019.83512. eCollection 2020.
9
MIR210HG promotes cell proliferation and invasion by regulating miR-503-5p/TRAF4 axis in cervical cancer.MIR210HG 通过调控 miR-503-5p/TRAF4 轴促进宫颈癌的细胞增殖和侵袭。
Aging (Albany NY). 2020 Feb 21;12(4):3205-3217. doi: 10.18632/aging.102799.
10
circ-MYBL2 Serves As A Sponge For miR-361-3p Promoting Cervical Cancer Cells Proliferation And Invasion.环状MYBL2作为miR-361-3p的海绵，促进宫颈癌细胞的增殖和侵袭。
Onco Targets Ther. 2019 Nov 20;12:9957-9964. doi: 10.2147/OTT.S218976. eCollection 2019.

本文引用的文献

1
Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.引入分子人乳头瘤病毒检测作为宫颈癌筛查的主要技术：依据证据改变当前模式。
Prev Med. 2017 May;98:5-14. doi: 10.1016/j.ypmed.2016.11.029. Epub 2017 Feb 6.
2
The time is now to implement HPV testing for primary screening in low resource settings.现在是在资源匮乏地区实施人乳头瘤病毒（HPV）检测用于初筛的时候了。
Prev Med. 2017 May;98:42-44. doi: 10.1016/j.ypmed.2016.12.030. Epub 2017 Feb 6.
3
Considerations for HPV primary screening in lower-middle income countries.低收入和中等收入国家人乳头瘤病毒初次筛查的考量因素
Prev Med. 2017 May;98:39-41. doi: 10.1016/j.ypmed.2016.12.029. Epub 2017 Feb 6.
4
Cervical cancer prevention in upper middle-income countries.中高收入国家的宫颈癌预防
Prev Med. 2017 May;98:36-38. doi: 10.1016/j.ypmed.2016.12.032. Epub 2017 Feb 6.
5
HPV-based cervical cancer screening- facts, fiction, and misperceptions.基于人乳头瘤病毒的宫颈癌筛查——事实、虚构与误解
Prev Med. 2017 May;98:33-35. doi: 10.1016/j.ypmed.2016.12.040. Epub 2017 Feb 6.
6
Protection against cervical cancer versus decreasing harms from screening - What would U.S. patients and clinicians prefer, and do their preferences matter?预防宫颈癌与减少筛查危害——美国患者和临床医生更倾向于什么，他们的偏好重要吗？
Prev Med. 2017 May;98:31-32. doi: 10.1016/j.ypmed.2016.12.041. Epub 2017 Feb 6.
7
Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening.宫颈癌筛查中对人乳头瘤病毒检测呈阳性的女性进行分流的方法。
Prev Med. 2017 May;98:15-20. doi: 10.1016/j.ypmed.2016.11.030. Epub 2017 Feb 6.
8
Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference.接种人乳头瘤病毒疫苗的女性的宫颈癌筛查：共识会议建议
Prev Med. 2017 May;98:21-30. doi: 10.1016/j.ypmed.2016.11.020. Epub 2016 Nov 25.
9
A review of human carcinogens--Part B: biological agents.人类致癌物综述——B部分：生物制剂
Lancet Oncol. 2009 Apr;10(4):321-2. doi: 10.1016/s1470-2045(09)70096-8.